D-dimer assay interference detected by the discrepancy in D-dimer concentrations at different dilutions: a case report.

Biochemia medica Pub Date : 2024-10-15 Epub Date: 2024-08-05 DOI:10.11613/BM.2024.031001
Marija Milić, Dejana Brkić Barbarić, Iva Lukić, Mirna Kirin, Vikica Buljanović, Vatroslav Šerić
{"title":"D-dimer assay interference detected by the discrepancy in D-dimer concentrations at different dilutions: a case report.","authors":"Marija Milić, Dejana Brkić Barbarić, Iva Lukić, Mirna Kirin, Vikica Buljanović, Vatroslav Šerić","doi":"10.11613/BM.2024.031001","DOIUrl":null,"url":null,"abstract":"<p><p>This case report describes interference from heterophilic antibodies in D-dimer assay. The interference was suspected due to discrepancies between D-dimer concentrations in the original sample and diluted samples, as well as inconsistent clinical findings. The patient's medical history, laboratory results, and imaging studies were considered in the investigation. Heterophilic antibodies, likely developed during the SARS-CoV-2 infection, were identified as the probable cause of interference. The interference was confirmed through various methods, including dilution studies, blocking heterophilic antibodies, and comparing results with an alternative D-dimer method. This case highlights the importance of recognizing and addressing interference in D-dimer testing, emphasizing the need for collaboration between clinicians and laboratory specialists.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334198/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemia medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11613/BM.2024.031001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This case report describes interference from heterophilic antibodies in D-dimer assay. The interference was suspected due to discrepancies between D-dimer concentrations in the original sample and diluted samples, as well as inconsistent clinical findings. The patient's medical history, laboratory results, and imaging studies were considered in the investigation. Heterophilic antibodies, likely developed during the SARS-CoV-2 infection, were identified as the probable cause of interference. The interference was confirmed through various methods, including dilution studies, blocking heterophilic antibodies, and comparing results with an alternative D-dimer method. This case highlights the importance of recognizing and addressing interference in D-dimer testing, emphasizing the need for collaboration between clinicians and laboratory specialists.

通过不同稀释度下 D-二聚体浓度的差异检测出 D-二聚体检测干扰:一份病例报告。
本病例报告描述了嗜异性抗体对 D-二聚体检测的干扰。怀疑干扰的原因是原始样本和稀释样本中的 D-二聚体浓度不一致,以及临床结果不一致。调查中考虑了患者的病史、实验室结果和影像学检查。嗜异性抗体可能是在 SARS-CoV-2 感染期间产生的,被确定为可能的干扰原因。干扰是通过各种方法确认的,包括稀释研究、阻断嗜异性抗体以及将结果与另一种 D-二聚体方法进行比较。这个病例突出了识别和处理 D-二聚体检测干扰的重要性,强调了临床医生和实验室专家合作的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信